We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.79B
AUM Growth
+$1.37B
(+16%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
15.58%
Holding
2,579
New
256
Increased
680
Reduced
638
Closed
183
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$31.5M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$20.5M |
| 3 |
THOR
THORATEC CORPORATION
THOR
|
+$13.5M |
| 4 |
eBay
EBAY
|
+$12.8M |
| 5 |
Korn Ferry
KFY
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$20.9M |
| 2 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$15.2M |
| 3 |
JPMorgan Chase
JPM
|
+$13.2M |
| 4 |
Pediatrix Medical
MD
|
+$12.5M |
| 5 |
Viatris
VTRS
|
+$9.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Industrials | 13.03% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 11.32% |
| 5 | Energy | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CVS Health
CVS
$137B
| $15.7M | 0.16% |
219,247
-4,736
| -2% | -$304K |
|
|
JWN
152
DELISTED
Nordstrom
JWN
| $15.6M | 0.16% |
252,921
+3,707
| +1% | +$223K |
|
153
Sinclair Inc
SBGI
$974M
| $15.6M | 0.16% |
437,021
+79,770
| +22% | +$2.68M |
|
|
ACAT
154
DELISTED
Arctic Cat Inc
ACAT
| $15.5M | 0.16% |
272,290
+48,945
| +22% | +$2.71M |
|
155
Texas Roadhouse
TXRH
$12.7B
| $15.5M | 0.16% |
558,017
+104,365
| +23% | +$2.84M |
|
|
WOOF
156
DELISTED
VCA Inc.
WOOF
| $15.4M | 0.16% |
492,640
+255,706
| +108% | +$7.46M |
|
157
Ziff Davis
ZD
$1.9B
| $15.4M | 0.16% |
354,815
+71,640
| +25% | +$3.08M |
|
158
RPM International
RPM
$13.7B
| $15.3M | 0.16% |
368,468
-5,697
| -2% | -$222K |
|
|
FITB
159
Fifth Third Bancorp
FITB
$52B
| $15.3M | 0.16% |
727,251
+56,940
| +8% | +$1.12M |
|
|
MDAS
160
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $15.3M | 0.16% |
769,835
+139,508
| +22% | +$3.14M |
|
|
ORB
161
DELISTED
ORBITAL SCIENCES CORP
ORB
| $15.2M | 0.16% |
651,395
+120,148
| +23% | +$2.75M |
|
|
PCP
162
DELISTED
PRECISION CASTPARTS CORP
PCP
| $15.2M | 0.15% |
56,310
-3,530
| -6% | -$888K |
|
|
DCH
163
Dauch Corp
DCH
$1.3B
| $15.1M | 0.15% |
739,391
+134,219
| +22% | +$2.56M |
|
164
Ross Stores
ROST
$76.6B
| $15.1M | 0.15% |
402,576
-4,334
| -1% | -$163K |
|
|
CYBX
165
DELISTED
CYBERONICS INC
CYBX
| $15M | 0.15% |
229,974
+43,083
| +23% | +$2.61M |
|
166
Moog Inc Class A
MOG.A
$13B
| $15M | 0.15% |
220,206
+38,909
| +21% | +$2.45M |
|
167
Terex
TEX
$7.98B
| $14.8M | 0.15% |
351,624
+7,740
| +2% | +$281K |
|
168
Freeport-McMoran
FCX
$90B
| $14.7M | 0.15% |
389,561
-14,537
| -4% | -$515K |
|
169
Robert Half
RHI
$3.61B
| $14.6M | 0.15% |
348,707
+46,154
| +15% | +$1.82M |
|
170
Centene
CNC
$31.3B
| $14.6M | 0.15% |
992,488
+48,640
| +5% | +$727K |
|
|
CKEC
171
DELISTED
Carmike Cinemas Inc
CKEC
| $14.6M | 0.15% |
523,598
+157,218
| +43% | +$3.73M |
|
|
ALR
172
DELISTED
Alere Inc
ALR
| $14.6M | 0.15% |
402,358
+72,840
| +22% | +$2.42M |
|
173
Verizon
VZ
$194B
| $14.6M | 0.15% |
296,236
+2,016
| +0.7% | +$99.1K |
|
174
Sabra Healthcare REIT
SBRA
$5.64B
| $14.5M | 0.15% |
556,271
+186,844
| +51% | +$4.82M |
|
175
Occidental Petroleum
OXY
$57B
| $14.4M | 0.15% |
158,102
+40,107
| +34% | +$3.66M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q4 2013 Portfolio in Review
As of Q4 2013, Glenmede Trust held 2,579 positions worth $9.79B, up 16% from $8.42B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust's Q4 2013 filing shows 256 new, 680 increased, 638 reduced and 183 closed positions. Its largest new stake was Korn Ferry: 518,057 shares worth $13.5M. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $20.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.
- Glenmede Trust's largest Q4 2013 buy was Korn Ferry: 518,057 shares worth $13.5M.
- Glenmede Trust added most to Stryker in Q4 2013, an estimated $31.5M increase.
- Glenmede Trust's biggest Q4 2013 reduction was JPMorgan Chase, cutting an estimated $13.2M.
- Glenmede Trust fully exited Vanguard FTSE All-World ex-US ETF in Q4 2013, selling an estimated $20.9M.
- Glenmede Trust's ten largest holdings make up 16% of its $9.79B portfolio in Q4 2013.
- Glenmede Trust opened 256 new positions and closed 183 in Q4 2013.
- Glenmede Trust's portfolio value rose 16% quarter-over-quarter to $9.79B.
Based on Glenmede Trust's 13F filing for Q4 2013, filed 31 Jan 2014.